Psychedelic Acquisition: Psycheceutical To Buy Majority Equity Stake In Maryland R&D Company
Publicly traded psychedelics company Psycheceutical Bioscience Inc. (OTC: BWVI) is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences’ majority equity stake.
